Recent Finacing
Recent Raise
Aukera Therapeutics is a Basel-based preclinical biotechnology spin-off developing first-in-class RAPTOR inhibitors to treat mTORC1-related diseases such as tuberous sclerosis complex (TSC).
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Aukera Therapeutics.
